Publications by authors named "Anne Rafowicz"

Claim this Profile
C
Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A.
Paul Saultier, Yves Guillaume, Virginie Demiguel, Claire Berger, Annie Borel-Derlon, Anne Rafowicz

J Pediatr· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet study.
Christoph Male, Nadine G Andersson, Anne Rafowicz, Ri Liesner, Karin Kurnik

Haematologica· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FVIII dosages in persons with haemophilia A treated with extended half-life products: From local biology to optimized patient management.
Andréas Perrier-Cornet, Aurélien Philippe, Thierry Lambert, Roseline d'Oiron, Anne Rafowicz

Haemophilia· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of adherence and consequences of the transition from adolescence to adulthood among young people with severe haemophilia (TRANSHEMO): study protocol for a multicentric French national observational cross-sectional study.
Noémie Resseguier, Natacha Rosso-Delsemme, Any Beltran Anzola, Karine Baumstarck, Vanessa Milien, Anne Rafowicz

BMJ Open· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased inhibitor incidence in severe haemophilia A since 1990 attributable to more low titre inhibitors.
H Marijke van den Berg, S Mojtaba Hashemi, Kathelijn Fischer, Pia Petrini, Rolf Ljung, Anne Rafowicz

Thromb Haemost· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.
Annelies Nijdam, Carmen Altisent, Manuel D Carcao, Ana R Cid, Ségolène Claeyssens-Donadel, Anne Rafowicz

Haematologica· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study.
Samantha C Gouw, H Marijke van den Berg, Kathelijn Fischer, Günter Auerswald, Manuel Carcao, Anne Rafowicz

Blood· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of 95 novel mutations in coagulation factor VIII gene F8 responsible for hemophilia A: results from a single institution.
Benoît Guillet, Thierry Lambert, Roseline d'Oiron, Valérie Proulle, Jean-Luc Plantier, Anne Rafowicz

Hum Mutat· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Injection of recombinant activated factor VII can induce transient increase in circulating procoagulant microparticles.
Valérie Proulle, Bénédicte Hugel, Benoit Guillet, Catherine Trichet, Anne Rafowicz

Thromb Haemost· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What factors influence the age at diagnosis of hemophilia? Results of the French hemophilia cohort.
Hervé Chambost, Valérie Gaboulaud, Brigitte Coatmélec, Anne Rafowicz, P Schneider

J Pediatr· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis